AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Scientific Advances on the HIV Care Continuum Presented at CROI

CROI logo

Among the scientific advances highlighted at the 21st Conference of Retroviruses and Opportunistic Infections (CROI)  in Boston, Massachusetts this week were a number of new studies addressing the provision of essential care to persons living with HIV infection, including diagnosis, linkage and retention in care, initiation of antiretroviral treatment (ART), and achievement of durable viral…

NIH’s Dr. Carl Dieffenbach Shares Highlights from CROI 2014 – March 5

Ron Valdiserri and Carl Dieffenbach

At the conclusion of sessions yesterday, March 5, at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, NIH’s Dr. Carl Dieffenbach sat down with Dr. Ron Valdiserri to discuss some of the day’s scientific highlights. In their video conversation below, Dr. Dieffenbach observes that three significant advances in HIV therapies were among…

PrEP Topics Examined at CROI 2014

Ronald Valdiserri

Among the many issues being discussed by the scientists, providers, and advocates gathered at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston this week is pre-exposure prophylaxis (PrEP) for HIV. In a number of clinical trials, daily oral PrEP has been proven to be an effective biomedical intervention for reducing the risk…

Conversations from CROI 2014: CDC’s Dr. Jonathan Mermin

video screenshot

While at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) this week, I was pleased to sit down with Dr. Jonathan Mermin, Director of CDC’s Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). Given that the HIV care continuum has been a topic of significant interest here at the conference, Dr. Mermin…

NIH’s Dr. Carl Dieffenbach Shares Highlights from CROI 2014 – March 4

Carl Dieffenbach at CROI

Yesterday, March 4, was the first full day of the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston. Over 4,000 HIV/AIDS research leaders from 85 countries are gathered at the annual scientific meeting discussing their work to understand, prevent, and treat HIV/AIDS and related infectious diseases. We’ve invited our colleague Dr. Carl Dieffenbach to…

NIH Seeks Input on HIV Cure Research Priorities

nih logo

The National Institutes of Health (NIH) is asking the scientific community to weigh in on what should be the highest priority research areas related to understanding HIV persistence and investigating strategies for eradicating or controlling remaining virus despite optimal antiretroviral treatment. Responses will be accepted through March 14 and will help guide the HIV Cure Initiative, a $100 million…

Scientific Advances in HIV and Viral Hepatitis To Be Examined This Week at CROI

CROI logo

The 21st Conference on Retroviruses and Opportunistic Infections (CROI)  takes place this week in Boston. This annual scientific meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and related infectious diseases provides a vital forum for translating laboratory and clinical research into progress against these diseases. More than 4,000 HIV/AIDS research leaders…

Sharpening Our Focus on Black MSM Vital to Meeting National Goals

CDC Pie Chart

As we observe National Black HIV/AIDS Awareness Day (NBHAAD) 2014, we are reminded that African Americans face the most severe burden of HIV/AIDS in the United States. Among African Americans, gay, bisexual and other men who have sex with men (Black MSM) are especially hard hit, representing more than half of all estimated new HIV infections…